Twitter | Search | |
Acceleron Pharma
Clinical stage biopharma focused on engaging the body's ability to rebuild and repair its own cells and tissues. Review our guidelines:
270
Tweets
134
Following
838
Followers
Tweets
Acceleron Pharma Jan 10
Thank you for joining us at . If you missed our presentation this past Monday, you can watch a replay of it here:
Reply Retweet Like
Acceleron Pharma Jan 10
We are pleased to announce that has published results from a Phase 2 study of an investigational agent in patients with both RBC transfusion-dependent and non-transfusion-dependent
Reply Retweet Like
Acceleron Pharma Jan 7
Live from , catch our presentation today at 2pm PT. More info on the webcast here:
Reply Retweet Like
Acceleron Pharma Jan 6
We have arrived at and are looking forward to an exciting and eventful week ahead of us! Don’t miss our presentation tomorrow at 2pm PT
Reply Retweet Like
Acceleron Pharma Jan 2
is one week away! Don’t miss our CEO, Habib Dable present on Monday, Jan 7 at 2pm PST. For more details, click here:
Reply Retweet Like
Acceleron Pharma Dec 18
An early diagnosis makes a difference with Pulmonary Hypertension. Read Debbie Price’s diagnosis story here:
Reply Retweet Like
Acceleron Pharma Dec 11
Did you know: The majority of cases are caused by a genetic deletion on chromosome 4? works daily to pioneer therapies that could improve muscle function and strength in neuromuscular diseases
Reply Retweet Like
Acceleron Pharma Dec 5
What a wonderful and exciting time we had at ! Only one month to go until we get to see you all again @
Reply Retweet Like
Acceleron Pharma Dec 5
We are still so elated that both the MEDALIST and BELIEVE phase 3 presentations were included in yesterday’s Best of ASH session. More info here:
Reply Retweet Like
Acceleron Pharma Dec 4
has been a success! We are thrilled and honored that both the MEDALIST and BELIEVE phase 3 trial presentations were included in today’s Best of ASH session.
Reply Retweet Like
Acceleron Pharma Dec 2
Reminder! Tomorrow morning at 6am PST / 9am EST, we will host a webcast & conference call to discuss highlights from the Phase 3 MEDALIST (MDS) & BELIEVE (b-thal) trials. More info here:
Reply Retweet Like
Acceleron Pharma Dec 2
Data from the MEDALIST Phase 3 trial in was announced today in a plenary session at . Details here
Reply Retweet Like
Acceleron Pharma Dec 2
Join us at the plenary session for the Phase 3 MEDALIST results @ 2pm PST today. You can find details here:
Reply Retweet Like
Acceleron Pharma Dec 2
We are looking forward to seeing you today at the plenary session for the Phase 3 MEDALIST results @ 2pm PST. More info here:
Reply Retweet Like
Acceleron Pharma Dec 2
If you haven’t already, please come see us @ booth #2359 to learn more about us and our pipeline of TGF-beta-based research in development for serious and rare diseases
Reply Retweet Like
Acceleron Pharma Dec 1
Along with our partner , today we announced Phase 3 BELIEVE data in beta-thalassemia at
Reply Retweet Like
Acceleron Pharma Dec 1
Don’t miss the oral presentation of Phase 3 BELIEVE trial results being presented today @ 2pm PST. More details here:
Reply Retweet Like
Acceleron Pharma Nov 30
We’re @ ! With 1000s of abstracts accepted, we’re honored that one of ours is among 6 chosen for presentation during the Plenary Scientific Session at the foremost hematology congress in the country. Details on our upcoming presentations here:
Reply Retweet Like
Acceleron Pharma Nov 28
Proud to announce that our product candidate for Charcot-Marie-Tooth disease--a neurological disorder causing severe muscle weakness--received Fast Track designation from US FDA
Reply Retweet Like
Acceleron Pharma Nov 27
Don’t miss our conference call and live audio webcast @ on Dec. 3 at 9am EST to review the MEDALIST and BELIEVE Phase 3 trial presentations. Click here for more info:
Reply Retweet Like